AzTrials
AzTrials

Distal Femur FracturesRSANCT01593176

Radiostereometric Analysis of Fracture Healing in Distal Femur Fractures

An observational study of Distal Femur Fractures, run by Massachusetts General Hospital at 2 sites in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The investigators are doing this research study to look at how distal femoral fractures (knee bone break) heal. In this study, the investigators will use Radiostereometric Analysis (RSA) to look at how the pieces of femur bone move as the bone heals. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Distal Femur Fractures
What is being tested?
Placement of RSA beads
Type of treatment
Surgery or procedure
How many people
30 participants
Where
2 sitesUnited States
Study dates
May 2012to Jun 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All potential subjects will be in the inpatient setting of Massachusetts General Hospital or Brigham \& Women's Hospital at the time of recruitment awaiting surgery on their distal femur fracture

Who may be able to join

  • Male or female subjects aged 18 and older
  • Isolated distal femur fracture requiring surgical stabilization with a LISS plate
  • Subjects who are able to return to MGH for follow-up during the year following their injury.

Who cannot join

  • Subjects with expected limited life span less than a year.
  • Subjects who were non ambulatory prior to their injury
  • Female subjects who are pregnant
  • Subjects who are treated with an orthopaedic implant other than the LISS
  • Subjects with bone structure illnesses.
  • Pathologic fractures secondary to neoplasm
  • Subject with a severe open distal femur fracture with vascular damage
  • Subjects who are unable to attend post-operative outpatient appointments at the MGH

Trial locations and contacts

2 sites in 1 country.

Mark S Vrahas, MD contact

617-726-2943

mvrahas@partners.org

Jordan H Morgan, BS contact

617-643-3653

jhmorgan@partners.org

United States2 sites, 2 recruiting
  • Massachusetts General Hospital

    Boston, Massachusetts, 02114

    Mark S Vrahas, MD, 617-726-2943, mvrahas@partners.org

    Mark S Vrahas, MD

    Recruiting
  • Brigham & Women's Hospital

    Boston, Massachusetts, 02115

    Michael J Weaver, MD, 617-525-8088, mjweaver@partners.org

    Michael J Weaver, MD

    Recruiting

Other trials in United States

About this study

The investigators are doing this research study to look at how distal femoral fractures (knee bone break) heal. In this study, the investigators will use Radiostereometric Analysis (RSA) to look at how the pieces of femur bone move as the bone heals. RSA is a special x-ray that uses radiographs to measure very small movements in the bone over time. The question that will be answered by this study is whether RSA can be used as a tool to monitor fracture healing.

Read the detailed description

Determining when a fracture has united can be very difficult. Plain radiographs are easy to obtain but are notoriously inaccurate for determining union. CT scans are more helpful, but are more costly and inconvenient. Artifacts from the metal implants often mask the visibility of the bone structure. In addition, the accuracy of CT scans for determining non-unions is not known. CT scanning will identify a nonunion when a clear persistent fracture line separates the fragments. Unfortunately, the scans often reveal some areas where bone has bridged the fracture, and other areas where the fracture line remains. Ultimately, no one knows the amount of bridging necessary to stop motion between the fragments. Often the best indication of fracture healing is the resolution of pain. However, patients' pain tolerance varies greatly. It is clear that our specialty needs better techniques to determine fracture union. This is particularly important since the market is introducing many new drugs that purport increased rate of fracture healing. If there are no standards to evaluate fracture healing, there is no way to determine drug efficacy.

Radiostereometric analysis (RSA) is a highly accurate, precise, safe and objective technique that uses radiographs to measure very small displacements and relative motion over time. It has been used successfully for some time to evaluate small changes in the position of prosthetic joints. There is some indication that this technique can also be used to evaluate healing by determining when motion between the fragments stops. A limited number of phantom model RSA in-vitro studies have proven useful for measuring the rigidity of different types of osteosyntheses methods. However, RSA has so far only been applied in a few in-vivo studies to evaluate fracture healing.

Osteosynthesis of distal femur fractures is challenging. Fractures are reduced through a large skin incision and often patients face non-union or union in a varus or valgus deformity after a long convalescence. That said, increased fracture fixation is now achievable through the newly invented locked angle screw plate system. The Synthes product, Less Invasive Stabilization System (LISS) plate is one example of this new system. The exact time of fracture healing, however, remains uncertain. No RSA in-vivo studies have been published among patients with distal femur fractures - but one RSA in-vitro study on 18 phantom distal femurs demonstrates RSA to be a relatively simple way to collect and analyze the relative motion between fragments fixed with the LISS.8 Given this, it should be possible to evaluate fragment motion in distal femur fractures stabilized using the LISS plate in order to evaluate healing.

At the time of surgery, sets of up to 9 RSA beads will be implanted on sides of the main fractures lines with the use of the inserter instrument and the image intensifier. In AO/OTA type 33A fractures, two sets will be implanted - one in the femoral shaft and one in the distal femoral epiphysis. In AO/OTA type 33C fractures with an extra fracture line through the epiphysis, three sets will be implanted - one in the femoral shaft, one in the main lateral condyle segment and one in the main medial condyle segment. No beads will be planted in comminuted bone fragments. Patients will be evaluated during outpatient follow-up visits standard for this fracture (2 weeks, 6 weeks, 3 months, 6 months and 1 year after surgery.)

The purpose of this study is to use RSA to evaluate fracture healing in distal femoral fractures osteosynthezed using the LISS.

Being tested
Placement of RSA beads
Keywords
Femur, Fracture, Radiostereometric Analysis
Medical subject headings
Femoral Fractures, Distal, Fractures, Bone

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Placement of RSA beadsProcedure or surgery

    Also called RSA Biomedical Tantulum Markers, Synthes Less Invasive Stabilization System Fixation Plate

    At the time of surgery sets of up to 9 RSA beads will be implanted on sides of the main fractures lines with the use of the inserter instrument and the image intensifier. In AO/OTA type 33A fractures two sets will be implanted - one in the femoral shaft and one in the distal femoral epiphysis. In AO/OTA type 33C fractures with an extra fracture line through the epiphysis, three sets will be implanted - one in the femoral shaft, one in the main lateral condyle segment and one in the main medial condyle segment. No beads will be planted in comminuted bone fragments. The fracture will then be plated with a LISS plate as it normally would.

Study groups in NCT01593176
Study groupRoleWhat they receive
Distal Femur Fracture, LISS PlatePatients presenting with a distal femur fracture requiring surgical fixation with a Less Invasive Stabilization System (LISS) plate will have placement of RSA beads for analysis.
Receives: Procedure: Placement of RSA beads

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in inter-fragmentary motion throughout the course of healing for distal femoral fractures.

    Use radiostereometric analysis to measure inter-fragmentary motion

    Measured: Change in inter-fragmentary motion from baseline at 2 weeks, 6 weeks, 3 months, 6 months and 1 year postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2012 (estimated)
  2. Study startMay 2012
  3. Primary completionMay 2015 (estimated)
  4. Study completionJun 2015 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01593176
Sponsor's protocol ID
2011P001012
Acronym
RSA
Status last verified
May 2015
First submitted
2 May 2012
Last updated
6 May 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Distal Femur Fractures, run by Massachusetts General Hospital at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 May 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mark S Vrahas, MD (617-726-2943, mvrahas@partners.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in inter-fragmentary motion throughout the course of healing for distal femoral fractures. (time frame: Change in inter-fragmentary motion from baseline at 2 weeks, 6 weeks, 3 months, 6 months and 1 year postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in